Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Riess

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
Hamostaseologie|November 2, 2012
[Dabigatran therapy--perioperative management and interpretation of coagulation tests]M Spannagl, R Bauersachs, E S Debus, et al.
Nuklearmedizin. Nuclear Medicine|September 12, 2006
Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy. Impact of PET with 18F-fluorodeoxyglucose on therapeutic decisionsH Amthauer, T Denecke, B Hildebrandt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 15, 2013
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxabanT Steiner, M Böhm, M Dichgans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 studyM Sinn, B V Sinn, J K Striefler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2016
SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 studyM Sinn, B V Sinn, J K Striefler, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Anticoagulation: the present and futureH Van Aken, C Bode, H Darius, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2009
Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppressionR Trappe, C Hinrichs, U Appel, et al.
Cancer Research|October 15, 1996
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumorsA S Lübbe, C Bergemann, H Riess, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
Leukemia|April 16, 2013
Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trialH Zimmermann, S Choquet, J Moore, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Hamostaseologie|November 2, 2012
[Dabigatran therapy--perioperative management and interpretation of coagulation tests]M Spannagl, R Bauersachs, E S Debus, et al.
Nuklearmedizin. Nuclear Medicine|September 12, 2006
Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy. Impact of PET with 18F-fluorodeoxyglucose on therapeutic decisionsH Amthauer, T Denecke, B Hildebrandt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 15, 2013
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxabanT Steiner, M Böhm, M Dichgans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 studyM Sinn, B V Sinn, J K Striefler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2016
SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 studyM Sinn, B V Sinn, J K Striefler, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Anticoagulation: the present and futureH Van Aken, C Bode, H Darius, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2009
Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppressionR Trappe, C Hinrichs, U Appel, et al.
Cancer Research|October 15, 1996
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumorsA S Lübbe, C Bergemann, H Riess, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
Leukemia|April 16, 2013
Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trialH Zimmermann, S Choquet, J Moore, et al.
Pageof 21